The Prospects for Developing an Effective Vaccine for COVID-19: When and How?


Ali I. Fattom

Senior Vice President of Vaccines Research and Development

BlueWillow Biologics


Headshot of Khalil E. Jahshan

Khalil E. Jahshan

Executive Director

Arab Center Washington DC


Speaker Bio

Dr. Ali Fattom is Senior Vice President of Vaccines Research and Development at BlueWillow Biologics, and has 25 years of experience in vaccine research and development. He is also Adjunct Professor at the University of Michigan Nanotechnology Institute for Medicine and Biological Sciences. He initiated his career as a vaccinologist at the National Institutes of Health, where he helped develop several vaccines including Pneumococcus conjugate vaccine, and headed the effort for developing a vaccine for S. aureus. He later joined Univax Biologics to pursue the development of conjugate vaccines against bacterial infections including Staphylococci. Following the merger between Univax and North American Biologics to form Nabi Biopharmaceuticals, Dr. Fattom assumed responsibility for other research activities and served as Vice President of Research from 2003 to 2010. He earned a B.S. from the Hebrew University of Jerusalem, an M.S. in microbiology from Tel Aviv University, and a Ph.D. in Microbial Ecology from the Hebrew University of Jerusalem. From 1983 to 1986, he held an assistant professorship at Birzeit University, West Bank. Dr. Fattom is the author of over 50 peer-reviewed publications and holds more than 10 patents.


Thursday May 21, 2020